glp-1 news today october 20 2025 Alarming rise in weight loss drug overdoses GI Adverse Effects of Glucagon-Like

Mississippi is one of 10 states that have not expanded Medicaid eligibility under the 2010 Affordable Care Act to everyone with an income under 138% of federal poverty level, or $21,597 this year

Theyve lost a lot of weight

Design, Synthesis and Biological Evaluation of Imidazo[1,2-a]pyridine Derivatives as Novel DPP-4 Inhibitors

Recently, the introduction of highly effective glucagon-like peptide-1 (GLP-1) receptor agonists has led to increased utilization of obesity medications in this population

SGLT2 Inhibitors No pharmacokinetic interaction studies have identified clinically meaningful changes when empagliflozin, dapagliflozin, or canagliflozin are combined with GLP-1 RAs

Costly GLP-1 Drugs Are Rarely Covered for Weight Loss by Marketplace Plans